Log in
Enquire now
‌

US Patent 11781133 Microarray based multiplex pathogen analysis and uses thereof

Patent 11781133 was granted and assigned to PathogenDX on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
PathogenDX
PathogenDX
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11781133
Patent Inventor Names
Melissa Rose May
Frederick Henry Eggers
Michael Edward Hogan
Date of Patent
October 10, 2023
Patent Application Number
17855067
Date Filed
June 30, 2022
Patent Citations
‌
US Patent 10272409 Methods and devices based upon a novel form of nucleic acid duplex on a surface
Patent Primary Examiner
‌
Amy M Bunker
CPC Code
‌
C12N 15/1086
‌
C12N 15/10
Patent abstract

Provided herein is a method for manufacturing a microarray system, for example, 3-dimensional lattice microarray system, for DNA sequence detection and analysis. A solid support, such as a plastic substrate, is contacted with a formulation containing a plurality of nucleic acid probes, a plurality of bifunctional polymer linkers, such as oligothymidine linkers, and a solvent mixture of water and a water-miscible liquid. The bifunctional polymer linkers are attached to the solid support and the water is evaporated. Then the nucleic acid probes are attached to the bifunctional polymer linker.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11781133 Microarray based multiplex pathogen analysis and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.